Which hedge funds own VRNA? VERONA PHARMA PLC, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in VRNA (VERONA PHARMA PLC) in their Q2 2026 13F filings, worth $0 in total.
- 0
- Holders
- 0
- New this quarter
- 0
- Exited this quarter
- $0
- Combined value
- –
- Share of managers holding
Holders, Q2 2026
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q4 2025 | 0 | 71 | 0.0% | $0 |
| Q3 2025 | 7 | 73 | 9.6% | $857m |
| Q2 2025 | 8 | 73 | 11.0% | $474m |
| Q1 2025 | 8 | 73 | 11.0% | $369m |
| Q4 2024 | 6 | 74 | 8.1% | $326m |
| Q3 2024 | 4 | 73 | 5.5% | $300m |
| Q2 2024 | 4 | 73 | 5.5% | $163m |
| Q1 2024 | 3 | 73 | 4.1% | $144m |
| Q4 2023 | 4 | 73 | 5.5% | $184m |
| Q3 2023 | 3 | 73 | 4.1% | $126m |
| Q2 2023 | 3 | 73 | 4.1% | $164m |
| Q1 2023 | 3 | 73 | 4.1% | $180m |
| Q4 2022 | 3 | 73 | 4.1% | $178m |
| Q3 2022 | 3 | 74 | 4.1% | $67.8m |
| Q2 2022 | 3 | 74 | 4.1% | $23.6m |
| Q1 2022 | 1 | 74 | 1.4% | $25.4m |
| Q4 2021 | 1 | 74 | 1.4% | $34.3m |
| Q3 2021 | 1 | 71 | 1.4% | $27.9m |
| Q2 2021 | 1 | 71 | 1.4% | $33.4m |
| Q1 2021 | 1 | 70 | 1.4% | $42.6m |
| Q4 2020 | 2 | 71 | 2.8% | $32.0m |
| Q3 2020 | 1 | 68 | 1.5% | $31.8m |
| Q2 2020 | 1 | 68 | 1.5% | $100k |
| Q1 2020 | 0 | 68 | 0.0% | $0 |
| Q4 2019 | 1 | 67 | 1.5% | $72.0k |
| Q3 2019 | 0 | 60 | 0.0% | $0 |
| Q2 2019 | 1 | 60 | 1.7% | $53.0k |
| Q1 2019 | 1 | 60 | 1.7% | $76.0k |
Who discovered VRNA first?
Earliest meaningful positions among the 13 tracked managers seen opening VRNA since Q1 2019.
| RA Capital Management, L.P. | Q3 2020 | 0.6% | Exited by Q1 2025 | +396% |
| Maverick Capital Ltd | Q4 2023 | 0.7% | Exited by Q3 2025 | +217% |
| Duquesne Family Office LLC | Q3 2024 | 0.7% | Exited by Q4 2025 | +147% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.